American Portfolios Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

American Portfolios Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$3.21K	Hold	100	–	–	﹤0.01%	2978
2022 Q2	$2.97K	Hold	100	–	–	﹤0.01%	3013
2022 Q1	$2.81K	Hold	100	–	–	﹤0.01%	3134
2021 Q4	$4.61K	Sell	100 -100	-50%	-$4.3K	﹤0.01%	2925
2021 Q3	$6.56K	Hold	200	–	–	﹤0.01%	2738
2021 Q2	$7.01K	Hold	200	–	–	﹤0.01%	2670
2021 Q1	$7.23K	Hold	200	–	–	﹤0.01%	2525
2020 Q4	$5.81K	Hold	200	–	–	﹤0.01%	2351
2020 Q3	$5.64K	Buy	+200	New	+$5.96K	﹤0.01%	2223
2018 Q2	–	Sell	-100	Closed	-$5.82K	–	2382
2018 Q1	$5.82K	Hold	100	–	–	﹤0.01%	1831
2017 Q4	$6.45K	Buy	+100	New	+$6.22K	﹤0.01%	1739

Other funds holding ANIP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

American Portfolios Advisors's ANIP Position: Q3 2022 in Review

American Portfolios Advisors held its ANI Pharmaceuticals (ANIP) position steady in Q3 2022 at 100 shares worth $3.21K. The position accounts for ﹤0.01% of the portfolio, ranked #2978.

American Portfolios Advisors first reported a position in ANIP in Q4 2017 and has held it in 11 quarters since. The position peaked at $7.23K in Q1 2021. 126 funds tracked by Wall St. Rank hold ANIP as of Q3 2022.

American Portfolios Advisors held 100 shares of ANI Pharmaceuticals worth $3.21K as of Q3 2022.
American Portfolios Advisors left its ANI Pharmaceuticals share count unchanged in Q3 2022.
ANI Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2978 holding.
American Portfolios Advisors first reported a position in ANI Pharmaceuticals in Q4 2017 and has held it in 11 quarters since.
American Portfolios Advisors's ANI Pharmaceuticals position peaked at $7.23K in Q1 2021.
126 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.